Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends

Huang, Junjie; Deng, Yunyang; Pun, Ching Nei; Lok, Veeleah; Zhang, Lin; Xu, Qiang; Lucero‐Prisno, Don Eliseo; Xu, Wanghong; Zheng, Zhi‐Jie; Elcarte, Edmar; Withers, Mellissa; Wong, Martin Cs

doi:10.1007/s12020-022-03274-7

Cited by 22 publications

(16 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We applied the National Cancer Institute Joinpoint Regression Program Version 4.9.1.0, 12 a technique used in many health care analyses, including cancer incidence, surgical trends, and health disparities research. [13][14][15][16] Joinpoint analysis allows one to describe annual percent change (APC) in incidence rate and to find inflection points and slopes for different time periods. 17 The software uses linear spline regression to evaluate APC and determines whether the changes in incidence over time are best described by a straight line or by multiple linear segments.…”

Section: Discussionmentioning

confidence: 99%

Age- and Race-Specific Changes in ESKD Incidence over Four Decades

Fwu,

Eggers,

Norton

et al. 2024

JASN

View full text Add to dashboard Cite

Introduction: Substantial changes in End Stage Kidney Disease (ESKD) incidence over four decades among Black and White Americans of different ages have been incompletely explored. Methods: We analyzed United States Renal Data System data from 1980-2019 to determine ESKD incidence trends among Black and White adolescent (13-17 years), adult (18-64 years), and older adult (≥65) populations. We used the National Cancer Institute Joinpoint Regression Program to estimate Annual Percent Change in ESKD incidence and to define points in time where a statistically significant change in Annual Percent Change slope occurred for each group. Results: ESKD incidence rose after 1980 for all groups, although the trends differed (p<.001). Growth in incidence slowed for most by 1993 and by 2006 the Annual Percent Change in ESKD incidence had declined for all groups except White adults, for whom rates continued to rise (p<0.05). By 2019 ESKD incidence among Black and White adolescents nearly returned to 1980 levels, but no other group achieved that degree of improvement. Nonetheless, the ESKD incidence among Black Americans exceeds that of White patients in every age group. Conclusions: Distinct patterns in ESKD incidence among patients of different age, sex, and racial groups are shown. These findings could reflect changes in dialysis acceptance rates, access to preventive healthcare, incidence of diabetes mellitus, implementation of evidence-based guidelines for treatment of chronic kidney disease, or other unrecognized factors. There may be population-specific opportunities to change the growth of the US ESKD population and address current racial disparities.

show abstract

Section: Discussionmentioning

confidence: 99%

Age- and Race-Specific Changes in ESKD Incidence over Four Decades

Fwu,

Eggers,

Norton

et al. 2024

JASN

View full text Add to dashboard Cite

show abstract

“…In 2022, Siegel et al in Cancer Statistics revealed that in the adult population in the United States, after decades of increase, TC incidence rates have now been declining partly because of recent changes in clinical practice designed to reduce overdetection. However, in a more recent analysis in 2023, Huang et al found that the incidence rate of TC increased in most countries among individuals irrespective of age groups (3,26). Additionally, the incidence rate increased in populations aged <40 y in several countries, including Poland (26).…”

Section: Introductionmentioning

confidence: 98%

“…However, in a more recent analysis in 2023, Huang et al. found that the incidence rate of TC increased in most countries among individuals irrespective of age groups ( 3 , 26 ). Additionally, the incidence rate increased in populations aged <40 y in several countries, including Poland ( 26 ).…”

Section: Introductionmentioning

confidence: 98%

“…However, in a more recent analysis in 2023, Huang et al found that the incidence rate of TC increased in most countries among individuals irrespective of age groups (3,26). Additionally, the incidence rate increased in populations aged <40 y in several countries, including Poland (26). Because the presentation of PTC in children is more severe than in adults, the extent of surgery is larger, and therapy also includes 131I therapy, leading to potential future therapeutic side effects.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma – a follow-up study

et al. 2023

View full text Add to dashboard Cite

BackgroundFollicular cell-derived thyroid carcinoma represents the vast majority of paediatric thyroid cancers (TCs). Papillary thyroid carcinoma (PTC) accounts for over 90% of all childhood TC cases, and its incidence in paediatric patients is increasing. The objective of this follow-up study was to present the outcome of ultrasound (US) and laboratory monitoring of paediatric patients with autoimmune thyroiditis (AIT) prior to the development of PTC.Patients and methodsThis prospective study included 180 children and adolescents (132 females; 73.3%) with a suspicion of thyroid disorder referred to the Outpatient Endocrine Department. The patients were divided into four groups: 1) 28 patients with a mean age of 10.7 [standard deviation (SD), 3.1] y, in whom PTC was detected during the active surveillance of AIT [AIT(+), PTC(+) follow up (F)]; 2) 18 patients with a mean age of 12.8 (SD, 3.4) y, in whom PTC and AIT were detected upon admission (A) [AIT(+), PTC(+) A]; 3) 45 patients with a mean age of 13.0 (SD, 3.4) y, in whom PTC was detected upon admission and AIT was excluded [AIT(-), PTC(+) A]; and 4) an age- and sex-matched control group of 89 patients with AIT and with a mean age of 9.4 (SD, 3.0) y. The analysis included clinical, US, and laboratory assessment results of children on admission (groups 1–4) and during follow-up (groups 1 and 4) in the Paediatric Endocrine Outpatient Department.ResultsUpon admission of those in group 1, the US evaluation revealed a hypoechogenic thyroid gland in 12 and an irregular normoechogenic gland in 16 patients. US monitoring revealed an increase in thyroid echogenicity and an increased irregularity of the thyroid structure during the follow-up period of all of the patients from group 1. Such changes were not noticed in group 4. PTC was diagnosed at the mean time of 3.6 y (3 mo–9 y) since AIT confirmation in group 1. The mean maximum PTC diameter as per the US was significantly smaller in group 1 than in groups 2 and 3 [13.2 (10.8) mm vs. 22.2 (12.8) and 22.05 (15.4) mm]. Fewer patients in group 1 were referred to 131I than in groups 2 and 3 (71.4% vs. 94.4 and 93.3%). Interestingly, significant differences were observed in the thyroglobulin antibody (TgAb)/thyroid peroxidase antibody (TPOAb) ratio between groups 2 and 3, as opposed to group 4, at the beginning of observation [15.3 (27.6) and 3.5 (8.8] vs. 0.77 (1.9)]. In group 1, after the follow-up, an increase in the TgAb/TPOAb ratio was observed [1.2 (9.8) to 5.2 (13.5)]. There were no significant differences between groups 1–3 in labeling index Ki67, lymph nodes metastasis, extrathyroidal extension, and angioinvasion. There were no associations between thyroid-stimulating hormone, TgAb, and the extent of the disease.ConclusionThe use of thyroid US focused on the search for developing tumours in the routine follow-up of patients with AIT may not only help in the early detection of thyroid malignancies that are not clinically apparent but may also influence the invasiveness of oncological therapy and reduce the future side effects of 131I therapy. We propose that the repeat evaluation of TPOAb and TgAb warrants further exploration as a strategy to determine TC susceptibility in paediatric patients with AIT in larger multicentre studies.

show abstract

“…Many cases were not found during the whole life until autopsy. [2][3][4][5] A small number of thyroid nodules were detected during physical examination. Most thyroid nodules can be identified by ultrasonography.…”

Section: Introductionmentioning

confidence: 99%

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Ding,

Jiao,

Piao

et al. 2023

Medicine

View full text Add to dashboard Cite

With the gradual development of immunotherapy for thyroid cancer, relevant research has increased. To better understand the current situation, development trend, evolution process, and research hotspots of this field, we conducted this comprehensive bibliometrics visual analysis. We retrieved papers published from 1980 to 2022 from Web of Science Core Collection on January 31, 2023. CiteSpace, Pajek, VOSviewer, R-Bibliometrix, and Scimago Graphics are the tools to perform the analysis. Analysis methods mainly include co-occurrence analysis and cluster analysis. Analysis objects are countries or regions, institutions, authors, journals, and keywords, etc. In terms of publication number, the recent decade has witnessed rapid growth. USA was the most prolific country and has the most influence in the cooperation team. Sweden took the lead in focus on this research field and lasted for 21 years. Garden State Cancer Center was released most papers (28). INSERM played a major role in institutional cooperation. Goldenberg DM published the most papers (48), with H-Index 25 and G-Index 43. Journal of Nuclear Medicine has the greatest papers published (41). The average impactor factor of the top 10 journals is 7.2058. The top keywords with high burst strength are: radioimmunotherapy (14.85), monoclonal antibody (13.78), non hodgkins lymphoma (12.54). The research field of immunotherapy for thyroid cancer will be further developed. This study provides a valuable reference for future research in the field.

show abstract

Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends

Cited by 22 publications

References 36 publications

Age- and Race-Specific Changes in ESKD Incidence over Four Decades

Age- and Race-Specific Changes in ESKD Incidence over Four Decades

Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma – a follow-up study

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Contact Info

Product

Resources

About